However, an increased number of TAMs, particularly CD68+ macrophages, was correlated with an increased likelihood of relapse after autologous hematopoietic stem-cell transplantation (P = 0.008) and shortened PFS (p = 0.03) in patients with classic Hodgkin’s lymphoma (HL) [77]. This evidence concerns the gene CD68 and Hodgkins lymphoma.